Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$0.57 - $1.16 $88,634 - $180,380
-155,500 Reduced 50.54%
152,200 $92,000
Q1 2023

May 15, 2023

SELL
$1.06 - $1.97 $270,618 - $502,941
-255,300 Reduced 45.35%
307,700 $341,000
Q4 2022

Feb 14, 2023

SELL
$1.4 - $25.4 $127,259 - $2.31 Million
-90,900 Reduced 13.9%
563,000 $821,000
Q3 2022

Nov 14, 2022

BUY
$0.36 - $36.0 $105,156 - $10.5 Million
292,100 Added 80.74%
653,900 $1.2 Million

Others Institutions Holding BNGO

About Bionano Genomics, Inc.


  • Ticker BNGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 290,140,000
  • Market Cap $58M
  • Description
  • Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...
More about BNGO
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.